Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts
Source abstract
Abstract
Actively targeted nanomedicines though conceptually attractive for tumor therapy are extremely hard to realize due to problems of premature drug leakage, excessive liver accretion, inadequate tumor uptake, and/or retarded drug release inside tumor cells. Here, we systemically studied the influence of disulfide crosslinking on the in vitro and in vivo performance of integrin-targeting micellar docetaxel (t-MDTX). Of note, t-M5DTX with a high disulfide content was clearly advantageous in terms of stability, intracellular drug release, anti-tumor activity toward αVβ3-overexpressing A549 cells, blood circulation and therapeutic efficacy in orthotopic A549-luc lung tumor-bearing mice. t-MDTX induced extraordinary tumor targetability with tumor-to-normal tissue ratios of 1.7-8.3. Further studies indicated that t-M5DTX could effectively eradicate αVβ3-overexpressing lung and prostate cancer patient-derived xenografts (PDX), in which ca. 80% mice became tumor-free. This integrin-targeting disulfide-crosslinked micellar docetaxel emerges as a promising actively targeted nanoformulation for tumor therapy. STATEMENT OF SIGNIFICANCE: Nanomedicines have a great potential in treating advanced tumor patients; however, their tumor-targeting ability and therapeutic efficacy remain unsatisfactory. In addition to PEGylation and ligand selection, particle size, stability and drug release behavior are also critical to their performance in vivo. In this paper, we find that small and cRGD-guided disulfide-crosslinked micellar docetaxel (t-MDTX) induces superior tumor uptake and retention but without increasing liver burden, leading to extraordinary selectivity and inhibition of αvβ3 overexpressing lung tumors. t-MDTX is further shown to effectively treat αvβ3-positive patient-derived tumor models, lending it a high potential for clinical translation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Ligand-installed nanocarriers toward precision therapy10.1002/adma.201902604 ↗
2. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
3. Actively targeted nanomedicines for precision cancer therapy: concept, construction, challenges and clinical translation10.1016/j.jconrel.2020.10.003 ↗
4. Intratumoral comparison of nanoparticle entrapped docetaxel (CPC634) with conventional docetaxel in patients with solid tumors10.1158/1078-0432.CCR-20-0008 ↗
5. A safe-by-design strategy towards safer nanomaterials in nanomedicines10.1002/adma.201805391 ↗
6. Polyplex micelle installing intracellular self-processing functionalities without free catiomers for safe and efficient systemic gene therapy through tumor vasculature targeting10.1016/j.biomaterials.2016.10.042 ↗
7. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile10.1126/scitranslmed.3003651 ↗
8. PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application10.1016/j.jconrel.2017.05.028 ↗
9. First-in-human assessment of cRGD-ZW800-1, a Zwitterionic, integrin-targeted, near-infrared fluorescent peptide in colon carcinoma10.1158/1078-0432.CCR-19-4156 ↗
10. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy10.1002/advs.201801899 ↗
11. Π electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer10.1016/j.biomaterials.2020.120432 ↗
12. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM using polymer-based delivery system10.1016/j.jconrel.2011.06.012 ↗
13. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy10.1016/S0168-3659(01)00275-9 ↗
14. Progress and challenges towards targeted delivery of cancer therapeutics10.1038/s41467-018-03705-y ↗
15. Cancer nanomedicine10.1038/s41568-022-00496-9 ↗
16. Challenges and strategies in anti-cancer nanomedicine development: an industry perspective10.1016/j.addr.2016.04.025 ↗
17. Biodegradable micelles based on poly(ethylene glycol)-b-polylipopeptide copolymer: a robust and versatile nanoplatform for anticancer drug delivery10.1021/acsami.7b10533 ↗
18. Emerging targeted drug delivery strategies toward ovarian cancer10.1016/j.addr.2021.113969 ↗
19. Transferrin functionization elevates transcytosis of nanogranules across epithelium by triggering polarity-associated transport flow and positive cellular feedback loop10.1021/acsnano.8b07231 ↗
20. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities10.2217/nnm-2018-0120 ↗
21. Apolipoprotein E peptide-guided disulfide-cross-linked micelles for targeted delivery of sorafenib to hepatocellular carcinoma10.1021/acs.biomac.9b01419 ↗
22. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer10.1016/j.jconrel.2021.12.002 ↗
23. Self-templated, green-synthetic, size-controlled protein nanoassembly as a robust nanoplatform for biomedical application10.1021/acsami.7b19201 ↗
24. Modulated fragmentation of proapoptotic peptide nanoparticles regulates cytotoxicity10.1021/jacs.6b11302 ↗
25. Immunotherapy of malignant Glioma by noninvasive administration of TLR9 agonist CpG nano-immunoadjuvant10.1002/advs.202103689 ↗
26. Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia
27. Small, smart, and LDLR-specific micelles augment sorafenib therapy of glioblastoma10.1021/acs.biomac.1c01103 ↗
28. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
29. Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy10.1016/j.jconrel.2022.08.003 ↗
30. The role of micelle size in tumor accumulation, penetration, and treatment10.1021/acsnano.5b02017 ↗
31. AZD9291 resistance reversal activity of a pH-sensitive nanocarrier dual-loaded with chloroquine and FGFR1 inhibitor in NSCLC10.1002/advs.202002922 ↗
32. Biodegradable nanoscale coordination polymers for targeted tumor combination therapy with oxidative stress amplification10.1002/adfm.201908865 ↗
33. Nora Graf, Diane R. Bielenberg, Nagesh Kolishetti, Christoph Muus, Jacqueline Banyard, Omid C. Farokhzad, S.J. Lippard, αVβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug, ACS Nano 6 (2012) 4530-4539.10.1021/nn301148e ↗
34. Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells
35. Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels10.1016/j.biomaterials.2006.06.011 ↗
36. Smart polymersomes dually functionalized with cRGD and fusogenic GALA peptides enable specific and high-efficiency cytosolic delivery of apoptotic proteins10.1021/acs.biomac.8b01243 ↗
37. Efficient near-infrared photosensitizer with aggregation-induced emission for imaging-guided photodynamic therapy in multiple xenograft tumor models10.1021/acsnano.9b07972 ↗
38. Tubulin-based nanotubes as delivery platform for microtubule-targeting agents10.1002/adma.202002902 ↗
39. Endosome-disrupting, and bioresponsive click nanogels fabricated via microfluidics for CD44-Targeted Cytoplasmic Delivery Of Therapeutic Proteins10.1021/acsami.9b05827 ↗
40. Polymeric micelles with alpha-glutamyl-terminated PEG shells show low non-specific protein adsorption and a prolonged in vivo circulation time10.1016/j.msec.2015.10.084 ↗
41. Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings10.1021/nn303030t ↗
42. alpha3beta1 integrin-targeting polymersomal docetaxel as an advanced nanotherapeutic for nonsmall cell lung cancer treatment10.1021/acsami.0c01069 ↗
43. Selective cell penetrating peptide-functionalized envelope-type chimeric lipopepsomes boost systemic RNAi therapy for lung tumors10.1002/adhm.201900500 ↗
44. Know thy PDX model10.1158/0008-5472.CAN-19-2023 ↗
45. Synergistic photothermal/photodynamic suppression of prostatic carcinoma by targeted biodegradable MnO2 nanosheets10.1080/10717544.2019.1631409 ↗
46. Microtubule-targeting agents: strategies to hijack the cytoskeleton10.1016/j.tcb.2018.05.001 ↗
47. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells10.1186/s12951-020-00604-7 ↗
48. Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles10.1016/j.jconrel.2020.09.046 ↗
49. Bioorthogonal coordination polymer nanoparticles with aggregation-induced emission for deep tumor-penetrating radio- and radiodynamic therapy10.1002/adma.202007888 ↗
50. CD44-targeted multifunctional nanomedicines based on a single-component hyaluronic acid conjugate with all-natural precursors: construction and treatment of metastatic breast tumors in vivo10.1021/acs.biomac.9b01012 ↗
51. Crosslinking induced reassembly of multiblock polymers: addressing the dilemma of stability and responsivity10.1002/advs.201902701 ↗
52. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking10.1002/smll.201201390 ↗
53. Role of micelle size in cell transcytosis-based tumor extravasation, infiltration, and treatment efficacy10.1021/acs.nanolett.3c00449 ↗
54. Cylindrical polymer brushes-anisotropic unimolecular micelle drug delivery system for enhancing the effectiveness of chemotherapy